Results for untargeted MS search on m/z: (+/-) mode
| Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| AN001172 | 60.0211 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 70.0079 | 1.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 74.0023 | 1.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 74.0023 | 1.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 87.9767 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 87.9798 | 0.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 88.0520 | 2.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 90.0315 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 90.0318 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 90.0320 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 92.0623 | 5.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 100.0522 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 101.9412 | 23.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 102.0316 | 1.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 105.9856 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 113.9929 | 1.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 115.9729 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 116.0470 | 2.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 117.9876 | 1.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 117.9878 | 1.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 118.0626 | 2.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 118.0627 | 2.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 122.0370 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 128.1201 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 129.0029 | 0.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 129.0425 | 0.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 129.0425 | 0.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 130.0630 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 130.0630 | 4.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 131.0536 | 1.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 131.9518 | 23.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 132.0418 | 2.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 132.0682 | 4.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 132.0685 | 4.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 132.0786 | 5.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 135.0446 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 135.0680 | 4.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | L-[15N]ANTHRANILIC ACID [ISTD] (M-H)- | 138.0446 | 5.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001172 | 144.0417 | 3.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 144.0940 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 145.1100 | 4.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 146.0524 | 4.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 146.0588 | 2.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 147.0890 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 147.9960 | 1.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 148.0161 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 148.0525 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 151.9921 | 1.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 157.0738 | 10.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 159.0358 | 12.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 159.0891 | 3.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 159.0894 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 159.9859 | 0.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 160.0379 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 160.0734 | 6.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 161.9841 | 0.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 162.0527 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 162.0527 | 1.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 164.0472 | 5.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 165.0788 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 166.0392 | 7.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 166.0620 | 6.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 167.9858 | 1.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 169.0314 | 1.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 169.0732 | 2.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 172.0192 | 3.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 172.0672 | 12.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 173.9983 | 2.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 175.0622 | 6.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 175.9633 | 0.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 175.9884 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 175.9900 | 0.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 176.0668 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 177.0457 | 4.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 180.0199 | 0.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 180.0556 | 5.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 181.0315 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 182.0575 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 182.0579 | 3.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 186.0452 | 1.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 186.9586 | 0.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 186.9590 | 1.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 187.1206 | 7.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 188.0144 | 5.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 188.0492 | 0.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.0555 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.0576 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.0980 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.0995 | 5.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.1003 | 4.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.1004 | 2.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 189.9577 | 13.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 191.9829 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 191.9848 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 193.0564 | 10.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 193.0567 | 12.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 193.0740 | 5.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 194.0942 | 15.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 195.0527 | 3.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 195.0531 | 11.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 195.0893 | 17.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 196.0038 | 5.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 197.0316 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 197.0322 | 7.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 197.0369 | 1.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 197.0791 | 1.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 198.0493 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 198.0496 | 4.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 200.0180 | 6.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 201.0556 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 201.8658 | 23.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 202.0027 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 202.0313 | 7.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 202.0451 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 202.0451 | 1.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 202.1204 | 12.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 203.1155 | 1.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 203.1155 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 203.1157 | 8.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 204.0090 | 3.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 204.0095 | 4.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 204.0899 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 205.0739 | 7.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 206.0322 | 5.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 206.0426 | 0.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 206.0434 | 13.42 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 206.0839 | 6.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | L-TRYPTOPHAN-15N2 [ISTD] (M-H)- | 206.0842 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001172 | 206.1671 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 207.0873 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 210.0877 | 0.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 211.0841 | 11.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 212.1411 | 18.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 213.0617 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 214.8534 | 0.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 215.1155 | 1.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 215.1521 | 12.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 216.0397 | 3.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 216.0398 | 3.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 216.0451 | 10.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 216.1364 | 14.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 219.0731 | 1.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 219.1106 | 3.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 219.1112 | 3.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 220.0067 | 0.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 221.0290 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 221.0716 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 222.1249 | 15.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 222.1409 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 223.0217 | 5.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 223.0380 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 225.1004 | 13.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 226.0695 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 226.1564 | 14.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 227.0194 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 227.0195 | 0.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 227.0254 | 8.09 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 227.0258 | 6.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 227.1158 | 12.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 228.1466 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 229.1677 | 14.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 229.9976 | 1.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 230.0609 | 11.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 230.0760 | 3.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 230.1417 | 10.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 230.1421 | 9.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 232.0046 | 5.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 233.0136 | 1.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 233.0670 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 233.0724 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 233.1258 | 1.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 234.0019 | 6.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 234.0271 | 7.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 234.1003 | 10.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 234.1619 | 19.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 234.1621 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 237.0166 | 4.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 237.0994 | 8.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 237.1001 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 238.0985 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 238.0992 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 238.9903 | 1.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 240.0668 | 6.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 240.0678 | 7.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 240.0717 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 240.0739 | 19.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 240.1358 | 16.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 240.1514 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 241.0043 | 5.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 241.0136 | 0.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 241.0572 | 0.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 242.0767 | 4.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 242.2243 | 22.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 243.0204 | 5.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 243.0206 | 3.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 243.0210 | 4.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 243.1833 | 22.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 243.1839 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 244.1683 | 18.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 244.1685 | 17.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 244.2033 | 21.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 244.2033 | 21.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 244.9168 | 0.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 245.1264 | 1.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 245.1449 | 16.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 246.1215 | 2.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 247.0455 | 4.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 247.0842 | 9.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 248.0369 | 3.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 248.1770 | 21.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 248.9481 | 0.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 248.9950 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 248.9962 | 0.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 249.0590 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 250.0699 | 3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 250.0878 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 250.1598 | 21.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 250.1929 | 22.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 251.0338 | 5.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 251.0615 | 12.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 251.1519 | 21.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 252.1032 | 14.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 252.2090 | 22.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 253.0519 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 253.0718 | 1.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 253.0943 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 254.0826 | 8.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 254.1152 | 14.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 254.1517 | 14.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 255.9360 | 4.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 255.9364 | 4.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 256.0013 | 5.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 256.0518 | 2.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 256.0959 | 7.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 256.1211 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 256.1214 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 256.9679 | 1.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 257.0201 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 257.1993 | 17.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 258.0421 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 258.0427 | 0.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 258.0566 | 18.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 258.1833 | 19.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 259.0844 | 12.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 260.1367 | 4.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 260.9956 | 2.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 261.0613 | 5.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 261.0667 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 261.1210 | 6.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 262.0354 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 263.9177 | 5.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 264.0059 | 1.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 264.0438 | 3.6 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 264.1233 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 264.1853 | 22.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 265.1170 | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 265.1653 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 265.9534 | 1.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 266.0827 | 10.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 266.1552 | 20.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 266.9969 | 1.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 267.1098 | 2.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 268.0981 | 11.35 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 268.1317 | 15.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 268.2405 | 22.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 269.9902 | 13.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0517 | 0.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0945 | 3.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0946 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0946 | 3.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0948 | 2.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0949 | 2.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0949 | 4.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.0951 | 4.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 270.2196 | 21.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 271.0145 | 3.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 271.2146 | 18.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 272.0777 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 272.2349 | 22.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 272.2350 | 21.35 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 272.2352 | 22.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 273.0971 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 273.1477 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 273.1935 | 15.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 273.1939 | 16.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 274.1317 | 6.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 274.1318 | 10.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 274.1322 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 274.1912 | 22.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 274.2143 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 275.1367 | 1.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 276.1112 | 3.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 276.1761 | 22.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 276.2089 | 22.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 277.0254 | 1.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 277.0689 | 3.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 277.0714 | 0.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 278.1520 | 21.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 278.1526 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 278.1585 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 278.1899 | 19.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 278.2235 | 22.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 278.2243 | 22.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.0887 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.0893 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.1104 | 9.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.1108 | 8.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.1110 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.1301 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 279.1599 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 280.0240 | 0.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 281.0674 | 0.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 281.1742 | 16.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 282.1074 | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 282.1081 | 4.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 282.1082 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 283.1391 | 12.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 283.2146 | 18.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.0763 | 2.42 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.0934 | 7.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.1258 | 7.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.1270 | 13.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.1406 | 6.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.1409 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.2100 | 11.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 284.2546 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 285.0275 | 2.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 286.0791 | 1.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 286.0796 | 0.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 286.0801 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 286.2141 | 21.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 287.0979 | 3.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 288.0955 | 2.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 288.1099 | 5.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 288.1473 | 12.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 288.1485 | 13.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 289.8415 | 0.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 289.8424 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 289.9194 | 10.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 290.1090 | 7.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 290.1094 | 12.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 290.9518 | 2.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 291.0506 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 291.0524 | 1.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 291.0719 | 4.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 291.0950 | 1.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 291.1665 | 4.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 291.2042 | 16.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 292.0042 | 10.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 292.1917 | 15.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 292.2403 | 22.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 293.1262 | 11.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 293.1264 | 11.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 293.1474 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 293.1475 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 293.1478 | 1.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.0611 | 2.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.0710 | 3.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.1214 | 5.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.1331 | 2.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.1827 | 17.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.1832 | 17.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.1864 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.1865 | 20.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 294.2189 | 21.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 296.0500 | 1.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 296.0579 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 296.1075 | 2.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 296.1967 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 296.2344 | 22.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 296.2706 | 23.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 297.0901 | 4.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 297.1350 | 2.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 297.1936 | 15.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.0713 | 5.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.0720 | 1.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.0734 | 4.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.1156 | 1.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.1250 | 3.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.1604 | 21.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.2479 | 22.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.2505 | 21.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 298.2507 | 22.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 299.1215 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.0283 | 5.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.0792 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.0978 | 5.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.1029 | 21.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.2659 | 22.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.9805 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 300.9837 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 301.0522 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 301.1420 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 301.2251 | 18.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 302.2207 | 15.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 302.2249 | 22.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 302.2456 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 304.0902 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 304.0904 | 0.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 304.0912 | 1.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 304.9308 | 4.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 305.0873 | 5.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 305.2201 | 16.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 305.9155 | 0.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 306.2554 | 22.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 307.0842 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 308.1198 | 10.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 308.1200 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 308.1286 | 14.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 308.1435 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 308.1524 | 17.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 308.2716 | 23.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 309.0067 | 3.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 309.0624 | 0.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 309.1048 | 0.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 309.1198 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 309.1431 | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 310.1192 | 2.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 310.1258 | 4.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 310.1259 | 4.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 310.1779 | 17.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 311.0088 | 2.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 311.0617 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 311.1053 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 311.1129 | 1.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 311.1708 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 312.0314 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 312.0980 | 12.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 312.1077 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 312.1085 | 0.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 312.2281 | 21.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 313.1017 | 3.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 313.9798 | 13.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 314.2442 | 22.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.0649 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.0665 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.2042 | 13.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.2044 | 14.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.2045 | 14.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.2074 | 11.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 315.8504 | 0.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 316.2611 | 21.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 317.0780 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 318.1075 | 5.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 318.1207 | 3.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 318.1807 | 22.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 318.2192 | 21.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 319.0826 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 320.1027 | 7.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 320.1863 | 11.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 320.1970 | 22.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 320.2349 | 21.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 320.2351 | 22.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 321.0402 | 1.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 321.0699 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 321.0699 | 1.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 321.0701 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 321.1323 | 5.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 321.1687 | 4.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 322.0941 | 2.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 322.2139 | 22.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 322.2504 | 22.28 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 323.0325 | 5.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 324.1471 | 13.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 324.2276 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 325.2362 | 11.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 326.0723 | 0.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 326.0738 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 326.1199 | 2.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 326.1345 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 327.1301 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 327.1320 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 328.0215 | 1.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 328.1605 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 328.2567 | 22.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 328.2617 | 22.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 329.0664 | 1.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 329.1241 | 1.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 329.1587 | 4.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 329.2203 | 16.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 330.1311 | 7.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 330.1977 | 14.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 330.2149 | 11.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 330.2771 | 23.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 331.1071 | 4.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 331.1235 | 3.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 331.1238 | 2.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 332.1216 | 2.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 332.1624 | 15.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 332.1838 | 8.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 332.1942 | 10.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 332.2718 | 23.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 333.9258 | 1.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 333.9677 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 334.0986 | 7.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 334.0992 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 334.0992 | 12.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 334.0994 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 334.1425 | 20.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 334.2873 | 23.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 336.1105 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 337.9878 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 338.0861 | 1.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 339.0600 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 339.2029 | 18.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 339.9808 | 0.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 340.1035 | 1.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 340.2240 | 22.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 341.1108 | 4.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 341.2311 | 6.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.0524 | 1.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.0536 | 0.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.0859 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.0949 | 4.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.1088 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.1249 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.1258 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 343.1815 | 18.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.0573 | 0.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.0958 | 10.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.1463 | 9.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.1774 | 21.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.1779 | 20.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.1960 | 22.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 344.9835 | 3.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 345.1429 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 345.2875 | 21.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1387 | 21.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1393 | 20.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1395 | 19.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1416 | 6.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1419 | 7.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1421 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1425 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1518 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.1777 | 14.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 346.2507 | 22.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 347.0386 | 1.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.0412 | 5.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1009 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1147 | 14.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1222 | 5.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1567 | 11.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1578 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1763 | 21.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.1935 | 14.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.2278 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.2512 | 15.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 348.2664 | 22.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 350.0195 | 3.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 350.0217 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 350.0222 | 4.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 350.1302 | 1.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 350.1756 | 18.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 350.2434 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 351.1057 | 1.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 351.1061 | 1.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 351.1253 | 10.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 351.1268 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 352.1075 | 10.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 352.1089 | 9.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 352.1340 | 14.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 352.1397 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 352.2247 | 18.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 352.2586 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 353.0770 | 2.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 354.0164 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 354.0559 | 12.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 354.0563 | 11.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 354.2075 | 22.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 355.0853 | 3.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 355.2464 | 8.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 356.0807 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 356.0809 | 7.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 356.1427 | 1.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 356.1655 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 356.2713 | 22.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 356.3282 | 22.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 357.2881 | 22.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 358.0067 | 0.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 358.0563 | 5.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 358.1088 | 12.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 358.1116 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 358.1576 | 20.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 358.2875 | 23.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 359.0275 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 359.1211 | 4.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 359.1535 | 4.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 360.0514 | 4.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 360.0518 | 4.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 360.1413 | 10.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 360.2313 | 22.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 361.1343 | 1.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 362.1044 | 1.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 362.1202 | 3.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 362.1362 | 6.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 362.1397 | 12.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 363.1082 | 2.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 363.1119 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 363.1127 | 0.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 363.1256 | 11.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 363.1297 | 20.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 363.2161 | 18.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 364.1408 | 7.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 364.1992 | 15.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 364.2192 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 365.1814 | 15.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 366.1249 | 13.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 366.1251 | 12.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 366.1252 | 12.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 366.1433 | 3.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 366.2529 | 22.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 368.0847 | 5.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 368.2196 | 16.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 368.2647 | 22.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 369.0202 | 1.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 369.0559 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 369.1399 | 3.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 369.2628 | 10.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 369.2629 | 10.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 370.0752 | 12.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 370.2161 | 22.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 370.2821 | 18.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 371.1141 | 10.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 372.2282 | 22.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 372.2653 | 22.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 372.9405 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 372.9793 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 373.1334 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 373.1370 | 5.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 373.1405 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 373.1641 | 9.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 374.0909 | 10.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 374.0916 | 9.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 374.1236 | 2.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 374.2439 | 22.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 374.9978 | 1.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 375.0338 | 1.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 375.2893 | 22.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 376.0396 | 11.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 376.1069 | 10.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 376.2825 | 22.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 377.1175 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 377.2081 | 6.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 378.0772 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 378.2007 | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 379.0626 | 1.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 379.0637 | 1.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 379.1033 | 1.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 379.1582 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 380.0980 | 4.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 380.1034 | 12.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 380.1043 | 9.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 380.1484 | 11.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 382.1183 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 382.1364 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 382.1809 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 384.0887 | 1.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 384.1338 | 8.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 384.1526 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 384.3242 | 23.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 385.0897 | 2.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 385.0897 | 2.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 385.3191 | 22.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 386.1966 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 387.1017 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 387.1209 | 4.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 387.3339 | 23.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 388.2931 | 19.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 389.0828 | 0.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 389.1222 | 0.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 389.1628 | 20.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 389.1628 | 20.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 389.3054 | 22.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 390.0913 | 1.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 390.0982 | 10.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 390.1264 | 2.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 390.1318 | 1.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 390.2008 | 22.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 391.1024 | 1.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 391.1146 | 1.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 391.1378 | 6.42 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 391.1382 | 9.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 391.2240 | 8.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 392.0412 | 0.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 392.0575 | 9.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 392.0575 | 12.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 392.0576 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 392.1467 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 392.2965 | 22.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 393.0777 | 1.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 393.2261 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 394.1201 | 9.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 394.1204 | 10.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 394.1585 | 1.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 395.0081 | 0.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 395.0595 | 20.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 395.1188 | 2.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 395.3033 | 18.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 396.0976 | 0.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 396.2276 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 396.2500 | 18.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 396.2502 | 22.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 396.2579 | 21.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.0515 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.0942 | 12.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.1013 | 2.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.1148 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.3163 | 22.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.3185 | 22.42 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 397.9415 | 0.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 398.0105 | 5.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 398.1852 | 14.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 399.2409 | 22.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 399.3349 | 22.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 399.9763 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 400.1229 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 400.2251 | 20.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 400.2275 | 19.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 401.1184 | 2.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 401.1643 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 401.3497 | 22.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.0609 | 1.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.0861 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.0866 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.0877 | 12.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.0914 | 1.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.0925 | 12.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.1198 | 3.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.1567 | 22.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 402.2999 | 22.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.0255 | 20.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.0996 | 8.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.1005 | 8.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.1139 | 3.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.1659 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.1719 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 404.3141 | 22.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 405.0535 | 1.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 405.1569 | 4.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 405.1606 | 1.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 405.1611 | 1.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 405.2393 | 10.35 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 406.0831 | 1.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 406.1152 | 8.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 406.1628 | 7.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 406.1662 | 13.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 407.1355 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 407.1383 | 1.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 407.1690 | 2.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 408.1024 | 20.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 408.1025 | 19.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 408.1302 | 5.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 408.1821 | 13.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.0323 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.0740 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.0835 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.1308 | 10.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.1311 | 9.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.1373 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 409.3038 | 16.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 410.3202 | 23.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 411.0751 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 411.1108 | 1.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 411.3341 | 23.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 411.9343 | 0.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 412.1301 | 5.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 412.2088 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 412.2116 | 22.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 413.0962 | 1.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 413.2014 | 22.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 413.3138 | 21.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 413.3515 | 23.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.1138 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.1259 | 19.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.1264 | 20.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.1283 | 6.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.1285 | 7.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.1290 | 8.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.2080 | 16.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.2083 | 15.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 414.2268 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.1267 | 0.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.1270 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.2678 | 10.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.3286 | 20.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.3295 | 21.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.3296 | 21.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.3298 | 22.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 415.9627 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 416.1018 | 10.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 416.1446 | 8.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 416.2151 | 22.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 417.0282 | 2.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 417.0291 | 2.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 417.3447 | 22.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 417.3448 | 21.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 418.0688 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 418.1610 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 418.1644 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 418.2317 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 418.2360 | 20.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 418.2921 | 21.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.0345 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.0370 | 1.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.0381 | 0.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.0728 | 15.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.0751 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.0780 | 12.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.1125 | 10.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 419.1128 | 9.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 420.0540 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 420.1230 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 420.1337 | 21.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 420.1416 | 6.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 420.3095 | 22.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 421.0246 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 421.0324 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.0438 | 11.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.1111 | 10.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.1433 | 7.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.1496 | 17.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.1501 | 16.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.1532 | 1.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.1629 | 18.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.2342 | 22.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.2343 | 22.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 422.2352 | 23.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 423.0466 | 1.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 423.1446 | 10.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 423.1643 | 2.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 423.1748 | 1.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.0402 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.0454 | 0.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.0678 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.0819 | 12.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.1015 | 3.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.1285 | 0.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.1291 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.1306 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.2901 | 23.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 424.3283 | 23.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 425.0992 | 2.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 425.9713 | 5.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 426.0836 | 20.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 426.1455 | 10.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 426.2393 | 2.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 427.1505 | 4.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 427.1794 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 428.1684 | 22.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 428.2977 | 21.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 429.1202 | 12.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 429.1228 | 1.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 429.3451 | 22.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 429.3459 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 430.0823 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 430.0868 | 16.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 430.0944 | 7.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 430.1233 | 6.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 430.1609 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 430.1877 | 22.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 431.0245 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 431.0532 | 0.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.0753 | 12.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.0853 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.1776 | 17.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.1782 | 15.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.1783 | 16.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.1912 | 18.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.2018 | 23.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.2583 | 10.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 432.9853 | 1.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.1155 | 1.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.1688 | 0.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.1689 | 1.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.2865 | 22.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.2891 | 21.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.3204 | 20.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 433.9938 | 10.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.0222 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1122 | 12.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1123 | 13.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1125 | 12.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1299 | 3.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1482 | 21.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1521 | 4.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1542 | 4.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.1803 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 434.3397 | 22.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 435.0435 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 435.1301 | 2.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 435.1309 | 3.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 436.0716 | 5.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 436.1114 | 7.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 436.1732 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 436.1809 | 19.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 436.1892 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 437.1151 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 437.9496 | 0.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 438.0764 | 10.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 438.2055 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 438.2660 | 21.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 438.3105 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 438.3493 | 23.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 438.9957 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 439.1409 | 10.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 439.1417 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 440.2048 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 440.2169 | 22.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 440.2785 | 21.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 441.0221 | 9.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 441.0239 | 0.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 441.0569 | 1.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 441.1257 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 441.1297 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 441.1397 | 5.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 442.0796 | 10.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 443.3415 | 22.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 444.1078 | 4.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 444.1091 | 4.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 444.1139 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 444.1482 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 444.2501 | 22.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 446.0237 | 0.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 446.1121 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 446.1124 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 446.1268 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 446.1925 | 17.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 446.2069 | 19.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 447.0451 | 0.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 447.0803 | 2.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 447.1220 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 447.1459 | 15.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 447.1576 | 2.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 448.1417 | 18.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 448.1984 | 1.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 448.3395 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 449.0224 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 449.1621 | 11.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 449.3135 | 17.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 449.3143 | 20.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 449.3144 | 20.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 450.1576 | 17.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 450.1718 | 18.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 450.1806 | 19.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 451.0491 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 451.1020 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 451.1772 | 13.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 451.1782 | 14.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 452.3124 | 23.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 452.3627 | 23.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 452.9712 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 453.1028 | 11.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 454.3403 | 20.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 455.0989 | 20.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 455.1041 | 1.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 455.1177 | 12.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 455.1186 | 11.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 455.1974 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 455.2002 | 1.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 456.1551 | 10.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 456.1772 | 3.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 457.2086 | 3.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 457.2105 | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 457.2250 | 23.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.0573 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.0664 | 1.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.1035 | 2.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.1769 | 22.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.2148 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.2325 | 22.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 458.3717 | 21.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.0993 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.1131 | 9.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.1142 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.1499 | 0.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.1735 | 2.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.2933 | 10.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 459.9719 | 12.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 460.2028 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 460.2036 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 460.2094 | 17.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 460.2094 | 18.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 460.2097 | 19.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 460.2097 | 19.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 461.1131 | 1.35 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 461.1234 | 9.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 462.0932 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 462.1845 | 3.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 463.1075 | 2.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 463.1215 | 5.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 463.2083 | 1.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 463.2466 | 1.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 463.2921 | 16.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.0561 | 9.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.0563 | 12.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.0568 | 12.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.1112 | 3.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.1689 | 3.6 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.2146 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.2327 | 24.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 464.2390 | 22.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 465.0862 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 465.1930 | 14.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 465.1932 | 15.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 466.1872 | 8.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 468.0775 | 12.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 469.0380 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 469.1371 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 469.8961 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 470.0724 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 470.0736 | 15.33 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 470.2085 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 470.2753 | 22.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 471.0754 | 12.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 471.0868 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 471.1441 | 11.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 471.1669 | 6.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 471.1789 | 1.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 471.2955 | 21.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 472.1319 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 472.1331 | 1.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 472.1661 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 472.3433 | 21.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 473.1659 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 475.0836 | 11.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 475.0846 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 476.0970 | 20.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 476.0979 | 19.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 476.1985 | 0.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 476.2044 | 19.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 476.2045 | 18.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 476.2047 | 18.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 477.1003 | 11.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 477.1142 | 1.09 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 478.0719 | 10.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 478.1144 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 478.1545 | 3.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 479.0968 | 1.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 479.1182 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 479.1738 | 1.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 479.1903 | 3.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 479.3017 | 22.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.0260 | 12.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.1168 | 12.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.1689 | 9.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.1874 | 2.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.2007 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.2036 | 7.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 480.2040 | 8.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 481.0839 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 481.1508 | 9.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1136 | 19.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1144 | 20.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1158 | 6.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1162 | 8.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1171 | 8.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1753 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.1845 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.2186 | 23.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 482.3724 | 21.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 483.0996 | 1.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 483.2551 | 10.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 483.3013 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 483.3020 | 21.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 484.0892 | 10.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 484.1319 | 8.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 484.1767 | 14.09 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 484.1774 | 16.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 484.1981 | 22.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 484.3874 | 21.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 485.1034 | 5.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 485.1051 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 485.1524 | 2.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 485.1703 | 1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 486.0383 | 15.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 486.0933 | 3.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 486.2194 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 487.1003 | 9.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 487.1697 | 1.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 488.0859 | 0.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 488.1026 | 9.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 488.2339 | 23.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 488.3127 | 10.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 489.0878 | 20.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 489.1079 | 1.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 489.1673 | 8.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 490.2214 | 22.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 491.9996 | 12.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 492.0550 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 492.1306 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 492.1393 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 492.1986 | 17.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 492.1988 | 1.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 492.1992 | 18.35 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 494.1161 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 494.1261 | 3.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 494.9443 | 12.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 495.1220 | 1.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 495.1528 | 1.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 496.0834 | 12.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 496.1504 | 12.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 496.1670 | 1.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 496.9371 | 12.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 498.0777 | 3.6 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 498.1126 | 6.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 498.1527 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 498.1810 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.1772 | 15.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.2961 | 20.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.2966 | 16.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.2969 | 18.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.2971 | 19.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.3261 | 22.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 499.3573 | 21.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 500.0692 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 500.1398 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 501.1124 | 1.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 501.1127 | 1.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 501.1302 | 2.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 501.2909 | 22.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.0988 | 13.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.0993 | 12.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.1208 | 3.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.1512 | 9.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.1794 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.1848 | 8.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.1995 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 502.2237 | 16.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 503.1291 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 503.3006 | 22.28 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 503.3013 | 22.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 505.0063 | 0.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 506.1280 | 1.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 508.0807 | 12.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 508.1032 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 508.2039 | 22.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 508.2095 | 7.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 508.3487 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 509.0379 | 0.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 509.1151 | 15.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 510.0981 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 510.1847 | 3.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 510.2423 | 1.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 511.1207 | 1.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 512.0524 | 12.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 512.0809 | 10.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 513.1781 | 9.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 513.2752 | 16.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 513.3062 | 21.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 513.3063 | 21.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 514.0962 | 1.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 514.0998 | 12.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 514.1537 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 514.1625 | 9.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 514.1633 | 10.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 514.1801 | 12.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 515.1330 | 15.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 515.1538 | 5.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 515.1724 | 12.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 515.2917 | 18.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 516.0202 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 516.1282 | 18.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 516.3217 | 19.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 517.1954 | 0.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 517.1967 | 1.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 517.3013 | 20.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 518.0872 | 12.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 518.1602 | 2.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 518.1621 | 3.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 519.1257 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 520.0615 | 1.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 521.0328 | 12.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 522.1601 | 22.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 523.1867 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 524.0545 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 524.1619 | 1.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 525.0909 | 5.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 525.1115 | 1.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 525.3447 | 22.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 526.1458 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 526.3506 | 19.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 526.3516 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 527.1727 | 13.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 527.1727 | 14.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 527.2660 | 21.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 527.3235 | 22.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 527.3261 | 22.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 527.3586 | 22.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 528.1090 | 1.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 528.1196 | 3.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 528.1764 | 12.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 528.1897 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 528.2033 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 529.2817 | 22.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 529.8550 | 0.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 530.2862 | 20.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 530.3746 | 23.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 531.0217 | 0.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 531.2467 | 1.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 531.3089 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 531.3153 | 9.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 532.0464 | 12.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 532.1743 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 532.2016 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 533.1854 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 533.2984 | 18.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 534.1183 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 534.1519 | 1.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 534.4619 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 537.0850 | 1.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 538.0599 | 12.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 538.0602 | 12.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 539.1784 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 539.2010 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 539.3222 | 21.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 539.3224 | 22.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 540.2852 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 540.2865 | 20.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 541.0608 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 541.3381 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 541.3382 | 22.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 542.1902 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 542.2253 | 1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 542.3446 | 18.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 542.3450 | 17.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 542.3456 | 18.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 543.1696 | 12.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 543.3406 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.0837 | 19.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.0844 | 20.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.0878 | 8.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.0882 | 8.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.1387 | 2.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.3143 | 21.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 544.3906 | 23.34 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 545.1880 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.0437 | 0.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.0577 | 10.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.1016 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.1503 | 1.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.1893 | 0.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.2410 | 2.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 546.2410 | 3.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 547.2114 | 0.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 548.1868 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 548.3040 | 1.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 548.3340 | 1.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.0718 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.1532 | 14.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.1547 | 13.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.1552 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.1692 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.2017 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 549.2531 | 3.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 550.1011 | 20.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 550.1018 | 19.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 550.1025 | 8.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 550.1385 | 9.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 550.1388 | 10.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 550.2047 | 23.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 551.0235 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 551.1481 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 551.2888 | 21.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 552.0758 | 10.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 552.0776 | 1.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 552.1188 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 552.1634 | 14.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 552.1896 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 553.2278 | 1.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 553.2896 | 22.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 553.3343 | 22.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 553.3390 | 22.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 553.3732 | 22.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 554.2048 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 554.9517 | 12.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 555.0867 | 9.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 555.1714 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 555.3561 | 22.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 556.1386 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 556.2196 | 23.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 556.2816 | 1.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 557.1690 | 3.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 557.3161 | 22.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 558.2083 | 22.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 558.2313 | 0.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 558.2329 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 559.1264 | 18.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 560.0422 | 15.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 560.2373 | 0.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 560.4778 | 22.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 560.4843 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 561.2736 | 21.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 562.3109 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 562.9682 | 0.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 564.0696 | 12.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 565.2006 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 565.2304 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 565.3383 | 22.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 565.3391 | 22.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 567.0916 | 1.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 567.2098 | 4.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 567.2841 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 567.3201 | 22.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 567.3539 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 567.3543 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 568.1747 | 0.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 568.2244 | 3.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 568.3177 | 21.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 569.1861 | 0.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 569.2209 | 2.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 569.3687 | 22.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 569.3691 | 22.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 570.0860 | 13.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 570.0874 | 12.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 570.1591 | 3.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 570.3174 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 572.1138 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 572.1995 | 9.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 574.0953 | 2.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 574.1235 | 9.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 574.1236 | 8.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 574.4987 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 576.0701 | 12.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 576.1688 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 576.2410 | 2.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 576.3347 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 577.1523 | 10.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 577.2568 | 1.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 577.2874 | 1.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 578.1212 | 8.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 578.2870 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 580.3958 | 22.28 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 580.3979 | 22.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 581.1517 | 0.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 581.1642 | 9.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 581.1955 | 1.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 581.2241 | 1.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 581.2945 | 21.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 581.3705 | 22.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 582.0872 | 12.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 582.3313 | 22.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 583.2756 | 18.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 584.1252 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 584.2398 | 1.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 584.4835 | 22.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 584.5015 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 585.2881 | 20.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 586.3525 | 21.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 586.4981 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 587.2119 | 2.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 588.5120 | 22.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 588.5142 | 22.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 589.3359 | 22.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 589.3379 | 22.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 590.1601 | 22.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 590.1613 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 590.2056 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 590.5253 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 591.3524 | 22.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 592.2143 | 3.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 593.2010 | 2.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 593.3690 | 22.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 594.1534 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 594.1795 | 9.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 594.1797 | 10.3 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 594.2107 | 3.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 594.2594 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 595.2276 | 20.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 595.3481 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 595.3859 | 23.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 596.1049 | 8.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 596.1077 | 9.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 596.1776 | 22.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 596.3520 | 22.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 596.4256 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 597.1410 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 597.2721 | 22.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 597.2909 | 15.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 598.4992 | 22.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 599.2349 | 1.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 600.0312 | 12.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 600.1610 | 2.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 600.1887 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 600.5145 | 22.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 600.5216 | 22.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 602.3453 | 21.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 602.5292 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 603.1335 | 0.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 604.1356 | 1.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 604.2416 | 3.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 605.2040 | 12.6 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 605.3360 | 21.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 606.0949 | 9.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 606.1344 | 0.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 606.2617 | 9.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 607.1802 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 607.3092 | 22.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 608.2786 | 1.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 608.3217 | 21.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 609.3254 | 22.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 609.3257 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 610.2540 | 1.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 610.3328 | 18.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 610.4252 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 611.3979 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 612.0695 | 8.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 612.0731 | 20.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | GLUTATHIONE (OXIDIZED) (M-H)- | 612.1524 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001172 | 612.1848 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 612.2960 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 612.5170 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 613.2295 | 11.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 613.2708 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 613.3380 | 22.15 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 613.3380 | 22.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 614.0739 | 1.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 614.4056 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 614.5232 | 22.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 614.5391 | 22.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 615.1565 | 11.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 615.3234 | 21.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 615.3511 | 22.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 616.1760 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 616.2410 | 10.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 617.1442 | 2.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 617.3691 | 22.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 618.0867 | 8.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 618.0967 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 618.1921 | 23.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 620.2773 | 2.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 622.1767 | 5.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 622.1853 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 622.1926 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 622.2278 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 622.3281 | 21.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 624.1505 | 3.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 624.2086 | 23.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 624.2494 | 1.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 625.3273 | 21.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 625.3470 | 17.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 626.1345 | 0.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 626.1954 | 22.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 626.5293 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 627.2457 | 12.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 627.2716 | 0.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 627.2850 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 627.2854 | 22.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 628.0413 | 8.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 628.5457 | 22.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 630.1766 | 0.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 630.2592 | 1.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 631.1806 | 1.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 631.2189 | 9.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 632.3688 | 21.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 633.1801 | 1.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 633.3273 | 22.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 633.3661 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 634.1338 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 634.4976 | 22.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 635.2719 | 19.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 635.3426 | 22.5 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 636.1489 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 636.2472 | 1.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 636.5142 | 22.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 637.2312 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 637.2357 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 637.3577 | 23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 637.3639 | 22.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.0726 | 13.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.1753 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.1759 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.2204 | 10.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.2206 | 1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.3077 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 638.3958 | 22.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 639.2849 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.0828 | 0.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.2131 | 1.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.2313 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.2331 | 2.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.2552 | 12.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.3959 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 640.4168 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 641.1827 | 10.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 641.1834 | 10.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 642.2179 | 10.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 642.2219 | 9.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 642.2561 | 8.28 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 644.2107 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 644.3234 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 645.1537 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 645.2823 | 0.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 646.2709 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 648.2047 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 648.5129 | 22.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 649.1753 | 0.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 649.3474 | 21.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 649.3620 | 20.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.1023 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.1361 | 10.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.2197 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.2844 | 0.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.3199 | 4.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.3975 | 22.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 650.5303 | 22.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 651.6164 | 23.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 652.4179 | 22.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 653.2994 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 654.2047 | 1.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 654.4132 | 22.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 655.1026 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 655.3139 | 22.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 656.1144 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 656.1491 | 9.6 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 656.2333 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 656.4250 | 22.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 657.3262 | 22.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 658.1481 | 22.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 658.2263 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 658.2279 | 1.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 658.3979 | 20.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 658.5135 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 659.2650 | 0.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 659.2847 | 3.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 660.2281 | 10.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 660.2284 | 9.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 660.3547 | 22.09 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 660.5144 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 661.2701 | 22.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 662.1608 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 662.1662 | 9.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | NAD (M-H)- | 663.1092 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
| AN001172 | 663.1650 | 10.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 663.2153 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 664.1648 | 22.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 664.4212 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 665.4266 | 22.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 666.0737 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 666.1883 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 666.2349 | 1.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 666.2350 | 1.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 666.4367 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 666.4861 | 24.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 668.1791 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 668.1836 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 668.1969 | 7.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 669.4825 | 24.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 670.1463 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 670.4368 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 670.4681 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 672.1242 | 9.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 672.2750 | 22.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 672.3003 | 4.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 674.5300 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 675.2225 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 675.2995 | 22.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 676.1859 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 676.1952 | 1.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 676.2471 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 676.4870 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 676.5444 | 22.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 677.3130 | 22.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 677.3130 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 677.3824 | 10.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 679.2129 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 680.2400 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 681.1699 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 681.2445 | 0.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 681.3261 | 22.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 682.2105 | 10.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 682.2563 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 682.3041 | 22.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 683.3413 | 22.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 684.2260 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 684.2747 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 684.2828 | 21.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 685.3218 | 22.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 686.0763 | 8.96 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 686.1799 | 23.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 686.2080 | 15.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 686.2084 | 14.58 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 686.2086 | 16.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 686.2265 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 687.2463 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 690.1613 | 5.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 690.1783 | 7.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 690.1791 | 9.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 690.1796 | 15.32 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 690.1807 | 12.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 691.1957 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 691.3342 | 22.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 692.1952 | 23.26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 692.2169 | 2.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 693.2731 | 3.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 694.1833 | 22.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 694.2989 | 8.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 694.5165 | 25.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 695.2512 | 0.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 695.2713 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 695.2793 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 696.1624 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 697.2307 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 697.3123 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 697.3181 | 8.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 697.5142 | 25.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 698.2240 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 698.2981 | 21.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 700.1690 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 700.1888 | 10.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 700.2247 | 12.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 700.3050 | 22.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 700.4524 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 701.2950 | 3.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 701.3097 | 22.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 701.3903 | 8.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 702.2222 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 703.3283 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 704.2211 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 705.1701 | 0.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 705.3438 | 23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 706.1368 | 10.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 706.1406 | 10.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 706.2937 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 707.2239 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 708.1814 | 2.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 708.1904 | 15.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 708.2135 | 1.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 708.2424 | 20.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 709.1345 | 10.22 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 710.1193 | 1.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 710.2353 | 7.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 710.3343 | 22.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 711.1312 | 10.17 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 711.2309 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 711.2514 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 712.2543 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 712.3105 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 713.0689 | 0.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 714.2308 | 2.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 714.2590 | 20.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 714.2597 | 19.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 714.2641 | 7.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 714.2668 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 716.1640 | 10.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 716.4523 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 717.2479 | 9.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 718.1555 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 718.2333 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 718.2962 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 720.4847 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 720.5408 | 24.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 721.1089 | 15.31 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 721.1625 | 10.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 721.2882 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 722.2054 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 722.2800 | 8.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 723.5427 | 22.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 724.1369 | 9.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 724.2326 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 724.5423 | 26.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 725.3113 | 22.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 726.2002 | 10.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 726.2031 | 9.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 726.4992 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 728.2261 | 1.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 730.0013 | 0.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 730.1705 | 12.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 731.2468 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 732.1026 | 1.37 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 732.1510 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 732.2138 | 9.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 732.2212 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 732.2862 | 3.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 732.4083 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 733.2328 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 733.4146 | 22.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 734.5555 | 24.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 736.1739 | 9.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 736.1750 | 8.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 736.2556 | 0.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 737.2788 | 3.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 738.1817 | 1.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 738.4243 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 739.2825 | 22.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 740.1482 | 1.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 741.1810 | 20.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 742.1632 | 9.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 743.2865 | 22.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 744.1707 | 2.91 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 745.2429 | 10.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 745.3011 | 22.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 745.3018 | 22.36 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 746.5561 | 24.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 748.5752 | 24.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 749.3092 | 22.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 749.4491 | 20.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 751.3266 | 22.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 752.1483 | 12.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.1656 | 23.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.1977 | 9.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.2291 | 12.97 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.2321 | 13.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.2342 | 12.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.2614 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 754.2673 | 3.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 755.2010 | 20.05 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 756.1684 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 756.1708 | 12.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 757.1353 | 9.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 758.1577 | 8.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 758.2412 | 12.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 758.2510 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 758.4970 | 19.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 758.5004 | 19.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 760.1004 | 12.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 760.1855 | 9.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 760.1858 | 23.27 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 761.0788 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 761.2389 | 9.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 763.2186 | 5.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 764.1697 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 765.2964 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 766.1762 | 1.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 767.4959 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 768.1231 | 12.71 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 768.2497 | 22.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 769.2172 | 3.19 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 771.3172 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 772.4518 | 22.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 773.3320 | 23.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 773.5132 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 774.2036 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 774.2048 | 1.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 774.3393 | 2.14 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 774.5894 | 24.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 775.5668 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 776.2294 | 20.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 776.2356 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 776.6028 | 25.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 777.5541 | 24.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 779.5702 | 25.42 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 780.1386 | 8.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 780.2085 | 12.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 782.1737 | 9.4 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 782.2422 | 8.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 782.2447 | 20.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 783.0605 | 1.09 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 783.4687 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 784.1682 | 12.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 784.2438 | 22.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 784.4415 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 785.1994 | 5.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 786.2015 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 786.2037 | 3.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 786.2845 | 8.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 788.1726 | 12.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 788.3427 | 0.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 788.4718 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 790.1244 | 12.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 790.1258 | 12.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 790.4631 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 791.2503 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 791.5683 | 25.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 791.6057 | 26.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 792.1731 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 792.2073 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 793.0668 | 12.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 793.3008 | 22.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 794.4883 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 796.1538 | 1.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 796.1617 | 0.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 796.1897 | 1.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 796.1949 | 2.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 797.1673 | 12.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 799.2749 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 799.4297 | 19.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 800.1442 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 800.3973 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 802.1743 | 9.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 804.3761 | 22.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 805.2630 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 805.5832 | 25.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 805.6205 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 806.1546 | 12.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 806.4129 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 807.2674 | 0.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 807.6012 | 26.38 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 809.1485 | 12.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 810.2231 | 10.43 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 812.2338 | 12.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 813.2318 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 813.2880 | 22.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 814.5443 | 24.25 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 816.2000 | 12.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 816.2027 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 816.5628 | 24.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 817.1505 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 818.2857 | 3.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 819.2434 | 9.87 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 819.6007 | 26 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 820.1355 | 12.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 822.1555 | 12.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 822.2811 | 9.92 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 822.2827 | 10.16 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 826.1121 | 12.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 826.2455 | 0.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 827.1493 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 827.5678 | 24.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 828.1730 | 1.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 828.2753 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 829.2588 | 0.72 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 830.6517 | 26.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 832.1718 | 12.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 832.1743 | 12.49 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 832.1940 | 0.69 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 832.2351 | 8.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 833.2858 | 22.64 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 833.6153 | 26.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 834.5215 | 24.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 835.1767 | 12.44 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 838.1563 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 839.3036 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 840.3167 | 3.61 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 841.1543 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 841.3178 | 23.01 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 841.4998 | 15.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 842.3112 | 3.63 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 844.1739 | 12.94 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 844.2187 | 20.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 844.2234 | 8.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 844.2235 | 8.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 844.2638 | 10.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 844.5875 | 25.39 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 845.5398 | 24.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 847.5553 | 25.41 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 848.2587 | 10.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 850.2365 | 8.57 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 850.2422 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 851.5715 | 24.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 852.4249 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 853.0777 | 12.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 853.5838 | 25.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 854.1387 | 12.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 854.1920 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 854.2691 | 8.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 855.1357 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 855.5989 | 25.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 856.4244 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 856.4579 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 856.6656 | 26.77 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 857.2378 | 0.78 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 857.6037 | 26.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 858.1358 | 12.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 858.4474 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 858.6829 | 27.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 860.2044 | 9.55 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 866.2717 | 10.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 866.2725 | 9.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 868.3575 | 1.8 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 868.3878 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 869.2659 | 3.6 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 870.2419 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 871.2622 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 872.2262 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 872.4031 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 873.1850 | 12.51 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 873.5715 | 25.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 873.6031 | 22.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 874.1700 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 874.4011 | 22.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 876.2000 | 10.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 876.2572 | 3.62 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 876.4049 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 878.4212 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 878.5301 | 24.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 879.5989 | 25.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 881.2747 | 22.54 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 881.3501 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 881.6135 | 25.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 883.6313 | 26.45 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 884.1892 | 12.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 885.4106 | 2.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 886.2049 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 886.2324 | 0.74 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 888.2533 | 10.12 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 888.2540 | 9.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 888.3756 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 890.2043 | 12.46 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 891.5316 | 25.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 893.3766 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 894.2136 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 894.2635 | 10.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 894.2666 | 9.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 899.5864 | 25.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 900.3756 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 901.1730 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 901.2055 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 901.6015 | 26.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 905.3781 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 907.2923 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 910.2329 | 10.11 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 912.1981 | 10.28 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 913.1760 | 12.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 914.2031 | 12.93 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 915.2070 | 0.79 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 917.3890 | 1.85 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 917.3993 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 919.5545 | 24.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 920.3975 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 921.5674 | 25.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 923.1859 | 0.75 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 923.2895 | 9.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 923.3444 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 923.4063 | 1.84 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 923.5858 | 25.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 924.4472 | 23.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 925.5999 | 26.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 926.3483 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 926.6694 | 27.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 932.1335 | 0.7 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 933.3617 | 1.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 933.3703 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 934.3758 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 936.3272 | 2.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 936.3717 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 939.3765 | 1.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 940.3882 | 20.02 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 941.5587 | 25.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 941.5949 | 22.99 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 942.2379 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 942.3872 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 945.2026 | 12.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 945.3456 | 1.07 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 946.4028 | 20.1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 946.5216 | 24.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 947.5848 | 25.56 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 949.6013 | 25.88 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 952.3418 | 3.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 952.5380 | 24.67 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 953.3027 | 9.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 955.3432 | 1.86 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 959.5217 | 25.53 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 962.3014 | 10.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 963.5397 | 24.89 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 966.2407 | 8.9 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 967.2236 | 1.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 968.3183 | 10.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 969.5891 | 26.52 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 970.1860 | 0.76 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 970.1915 | 1.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 975.2771 | 22.65 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 977.3560 | 20.03 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 978.2770 | 1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 978.2774 | 10.2 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 981.2781 | 1 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 981.2787 | 10.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 981.3666 | 1.73 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 981.5132 | 24.81 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 983.2767 | 10.18 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 983.3545 | 20.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 984.1775 | 1.08 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 984.2730 | 10.24 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 987.5429 | 24.82 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 989.5540 | 25.04 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 991.5702 | 25.68 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 992.3022 | 9.98 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 993.5912 | 26.13 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 994.3166 | 10.21 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1182.3398 | 9.59 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1490.6503 | 11.42 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1605.6810 | 11.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1627.6610 | 11.66 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1645.7076 | 12.23 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1716.7144 | 12.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1734.7227 | 11.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1738.6934 | 12.29 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1756.7039 | 11.48 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | 1790.6357 | 8.47 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | GDPMANNOSE (M-H)- | 0.83 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | ZEATIN [ISTD] (M+CL)- | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | ZEATIN [ISTD] (M-H)- | 3.95 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells | |
| AN001172 | N-ACETYL-L-LEUCINE (M-H)- | 7.06 | Minutes | ST000748 | NEGATIVE | Agilent 6530 QTOF | Reversed phase | Human | Cultured cells |
